As of 2024-12-12, the Relative Valuation of Tonix Pharmaceuticals Holding Corp (TNXP) is (16.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.20 USD, the upside of Tonix Pharmaceuticals Holding Corp based on Relative Valuation is -8349.8%.
The range of the Relative Valuation is (15.62) - (14.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 31.4x | 26.5x |
| Forward P/E multiples | 19.1x - 20.1x | 19.6x |
| Fair Price | (15.62) - (14.58) | (16.68) |
| Upside | -7823.6% - -7308.2% | -8349.8% |
| Date | P/E |
| 2024-12-11 | -0.27 |
| 2024-12-10 | -0.27 |
| 2024-12-09 | -0.26 |
| 2024-12-06 | -0.25 |
| 2024-12-05 | -0.24 |
| 2024-12-04 | -0.24 |
| 2024-12-03 | -0.26 |
| 2024-12-02 | -0.26 |
| 2024-11-29 | -0.26 |
| 2024-11-27 | -0.26 |
| 2024-11-26 | -0.26 |
| 2024-11-25 | -0.27 |
| 2024-11-22 | -0.26 |
| 2024-11-21 | -0.28 |
| 2024-11-20 | -0.26 |
| 2024-11-19 | -0.22 |
| 2024-11-18 | -0.18 |
| 2024-11-15 | -0.18 |
| 2024-11-14 | -0.19 |
| 2024-11-13 | -0.20 |
| 2024-11-12 | -0.20 |
| 2024-11-11 | -0.19 |
| 2024-11-08 | -0.19 |
| 2024-11-07 | -0.20 |
| 2024-11-06 | -0.19 |
| 2024-11-05 | -0.20 |
| 2024-11-04 | -0.20 |
| 2024-11-01 | -0.19 |
| 2024-10-31 | -0.20 |
| 2024-10-30 | -0.21 |
| 2024-10-29 | -0.23 |
| 2024-10-28 | -0.25 |
| 2024-10-25 | -0.23 |
| 2024-10-24 | -0.22 |
| 2024-10-23 | -0.23 |
| 2024-10-22 | -0.25 |
| 2024-10-21 | -0.26 |
| 2024-10-18 | -0.25 |
| 2024-10-17 | -0.25 |
| 2024-10-16 | -0.22 |
| 2024-10-15 | -0.19 |
| 2024-10-14 | -0.21 |
| 2024-10-11 | -0.20 |
| 2024-10-10 | -0.19 |
| 2024-10-09 | -0.20 |
| 2024-10-08 | -0.19 |
| 2024-10-07 | -0.20 |
| 2024-10-04 | -0.19 |
| 2024-10-03 | -0.17 |
| 2024-10-02 | -0.18 |